73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Noninvasive technique to assess brain tumors in children and make treatment less toxic

Noninvasive technique to assess brain tumors in children and make treatment less toxic

by Chris Speight,University of BirminghamCredit: CC0 Public DomainGround-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhoo

Noninvasive technique to assess brain tumors in children and make treatment less toxic

by Chris Speight,University of BirminghamCredit: CC0 Public DomainGround-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhoo
Oral paclitaxel yields better outcomes than intravenous paclitaxel for metastatic breast cancer

Oral paclitaxel yields better outcomes than intravenous paclitaxel for metastatic breast cancer

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainMetastatic breast cancer patients who received an oral formulation of the chemotherapy drug paclitaxel had better response and

Oral paclitaxel yields better outcomes than intravenous paclitaxel for metastatic breast cancer

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainMetastatic breast cancer patients who received an oral formulation of the chemotherapy drug paclitaxel had better response and
Researchers identify an Achilles' heel in neuroblastoma

Researchers identify an Achilles' heel in neuroblastoma

by Molly Chiu,Baylor College of MedicineThe image shows magnified neuroblastoma cells. Credit: Baylor College of MedicineNeuroblastoma, a childhood cancer that develops from neural cells on the

Researchers identify an Achilles' heel in neuroblastoma

by Molly Chiu,Baylor College of MedicineThe image shows magnified neuroblastoma cells. Credit: Baylor College of MedicineNeuroblastoma, a childhood cancer that develops from neural cells on the
The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer

The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer

byThe Spanish National Cancer Research CentreRAF1. Credit: CNIOOne of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes—genes that cause cancer

The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer

byThe Spanish National Cancer Research CentreRAF1. Credit: CNIOOne of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes—genes that cause cancer
Immunotherapy may become new first line treatment in some metastatic colorectal cancers

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

byEuropean Society for Medical OncologyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Immunotherapy with nivolumab and low-dose ipilimumab could become a new fi

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

byEuropean Society for Medical OncologyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Immunotherapy with nivolumab and low-dose ipilimumab could become a new fi
Basic research opens up new therapeutic opportunities for fighting leukemia

Basic research opens up new therapeutic opportunities for fighting leukemia

byUniversity of Veterinary Medicine—ViennaGenome-wide CRISPR/Cas9-based loss-of-function screen identifies genetic dependencies of STAT3Y640F-driven cells a) Schematic illustration of a competit

Basic research opens up new therapeutic opportunities for fighting leukemia

byUniversity of Veterinary Medicine—ViennaGenome-wide CRISPR/Cas9-based loss-of-function screen identifies genetic dependencies of STAT3Y640F-driven cells a) Schematic illustration of a competit
Survey: Most women unaware of the signs of an aggressive form of breast cancer

Survey: Most women unaware of the signs of an aggressive form of breast cancer

by Ohio State University Comprehensive Cancer CenterDr. Ko Un Park consults with a patient at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Sol

Survey: Most women unaware of the signs of an aggressive form of breast cancer

by Ohio State University Comprehensive Cancer CenterDr. Ko Un Park consults with a patient at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Sol
Are inflammatory bowel disease patients more at risk of colorectal cancer

Are inflammatory bowel disease patients more at risk of colorectal cancer

In a recent study published in the journalFrontiers in Medicine, researchers analyzed data from a large cohort of inflammatory bowel disease (IBD) patients and compared the risk and frequency of

Are inflammatory bowel disease patients more at risk of colorectal cancer

In a recent study published in the journalFrontiers in Medicine, researchers analyzed data from a large cohort of inflammatory bowel disease (IBD) patients and compared the risk and frequency of
After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

October 23, 2023Dylann Cohn-EmeryContinued treatment with lenvatinib monotherapy after the completeion of combination therapy with pembrolizumab and lenvatinib resulted in sustained clinical benefit v

After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

October 23, 2023Dylann Cohn-EmeryContinued treatment with lenvatinib monotherapy after the completeion of combination therapy with pembrolizumab and lenvatinib resulted in sustained clinical benefit v
Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

September 22, 2023Chris RyanTreatment with the combination of enfortumab Vedotin and pembrolizumab led to an improvement in overall survival and progression-free survival compared with chemotherapy in

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

September 22, 2023Chris RyanTreatment with the combination of enfortumab Vedotin and pembrolizumab led to an improvement in overall survival and progression-free survival compared with chemotherapy in
Clinical trial reveals new subtypes of advanced pancreatic cancer

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne
New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

In a study published inCancer Discovery, researchers from Canada tested the use of a multimodal liquid biopsy assay based on cell-free DNA (cfDNA) for early cancer detection in patients with Li-

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

In a study published inCancer Discovery, researchers from Canada tested the use of a multimodal liquid biopsy assay based on cell-free DNA (cfDNA) for early cancer detection in patients with Li-